Clinical Trials
3 trialsNCT04634435 2025-01-20
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Biohaven Pharmaceuticals, Inc.
Phase 1 Completed
NCT00515450 2010-07-30
Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
Benesis Corporation
Phase 3 Completed
NCT00294476 2006-10-12
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
GammaCan
Phase 2 Unknown